Metabolic or bariatric surgery may be more effective than standard medical treatments for the long-term control of type 2 diabetes in obese patients, according to a new study by King's College London and the Universita Cattolica in Rome, Italy. The study, published in The Lancet, is the first to provide data on five-year outcomes of surgery from a randomized clinical trial specifically designed to compare this new approach against standard medical therapy for the treatment of type 2 diabetes.
Surgery achieves better long-term control of type 2 diabetes than standard medical therapy
Read the full press release here
This and other ground-breaking studies will be presented at WCITT2D 2015 & DSS-II being held in London, 28-30 September, 2015.
Register today for your place at an event that has the potential to shape the future of metabolic surgery and diabetes care for years to come.